COSCIENS Biopharma (CSCI) Long Term Liabilities

Annual Total Long Term Liabilities

$1.40 M
-$1.07 M-43.34%

December 1, 2023

Summary

Performance

1-Year Change

-43.34%

3-Year Change

-49.46%

5-Year Change

+153.64%

15-Year Change

+46.7%

CSCI Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.92%
CSCI annual total long term liabilities is higher than 24.92% of companies in Healthcare sector

High & Low

All-time High

$3.72 M
CSCI annual total long term liabilities is currently -62.49% below its historical high of $3.72 million

3-Year Low

$1.40 M
CSCI annual total long term liabilities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIbalance sheetmetrics:

Annual Total Liabilities

$2.71 M
CSCI annual total liabilities is $2.71 million

Annual Current Liabilities

$4.54 M
CSCI annual total current liabilities is $4.54 million

Annual Total Assets

$23.70 M
CSCI annual total assets is $23.70 million

Annual Current Assets

$36.37 M
CSCI annual total current assets is $36.37 million

Quarterly Long Term Liabilities

$15.59 M
+$1.67 M+11.98%

September 1, 2024

Summary

Performance

3-Month Change

+11.98%

1-Year Change

+1016.38%

3-Year Change

+1016.38%

5-Year Change

+1016.38%

CSCI Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.5%
CSCI quarterly total long term liabilities is higher than 48.5% of companies in Healthcare sector

High & Low

All-time High

$15.59 M
CSCI quarterly total long term liabilities is currently at an all-time high

3-Year Low

$1.30 M
CSCI quarterly total long term liabilities is currently +1103.52% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIbalance sheetmetrics:

Quarterly Total Liabilities

$23.75 M
CSCI quarterly total liabilities is $23.75 million

Quarterly Current Liabilities

$8.17 M
CSCI quarterly total current liabilities is $8.17 million

Quarterly Total Assets

$43.77 M
CSCI quarterly total assets is $43.77 million

Quarterly Current Assets

$28.22 M
CSCI quarterly total current assets is $28.22 million

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

Annual Total Long Term Liabilities

$1.40 M
CSCI annual total long term liabilities is $1.40 million

Annual Long Term Debt

$1.40 M
CSCI annual long term debt is $1.40 million

CSCI Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-43.3%+1016.4%
3 y3 years-49.5%+1016.4%
5 y5 years+153.6%+1016.4%

CSCI Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-43.3%at lowat high+1103.5%
5 y5-year-49.5%at lowat high+1103.5%
alltimeall time-62.5%+2123.4%at high>+9999.0%

COSCIENS Biopharma Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$15.59 M(+12.0%)
Jun 2024
-
$13.92 M(+974.7%)
Mar 2024
-
$1.30 M(-7.2%)
Dec 2023
$1.40 M(-43.3%)
$1.40 M(-19.0%)
Sep 2023
-
$1.72 M(-16.2%)
Jun 2023
-
$2.06 M(-11.4%)
Mar 2023
-
$2.32 M(-5.7%)
Dec 2022
$2.46 M(+33.2%)
$2.46 M(+9.5%)
Sep 2022
-
$2.25 M(+0.2%)
Jun 2022
-
$2.25 M(+13.9%)
Mar 2022
-
$1.97 M(+6.6%)
Dec 2021
$1.85 M(-33.0%)
$1.85 M(-28.6%)
Sep 2021
-
$2.59 M(-4.9%)
Jun 2021
-
$2.73 M(-0.3%)
Mar 2021
-
$2.73 M(-1.0%)
Dec 2020
$2.76 M(+12.2%)
$2.76 M(+22.6%)
Sep 2020
-
$2.25 M(-0.2%)
Jun 2020
-
$2.26 M(+1.7%)
Mar 2020
-
$2.22 M(-9.8%)
Dec 2019
$2.46 M(+347.2%)
$2.46 M(-6.8%)
Sep 2019
-
$2.64 M(-3.0%)
Jun 2019
-
$2.72 M(-1.3%)
Mar 2019
-
$2.76 M(+401.2%)
Dec 2018
$550.50 K(-42.2%)
$550.50 K(-8.5%)
Sep 2018
-
$601.70 K(-9.9%)
Jun 2018
-
$668.00 K(-12.2%)
Mar 2018
-
$761.10 K(-20.0%)
Dec 2017
$951.80 K(-11.9%)
$951.80 K(-21.1%)
Sep 2017
-
$1.21 M(+30.5%)
Jun 2017
-
$924.70 K(-1.2%)
Mar 2017
-
$935.60 K(-13.7%)
Dec 2016
$1.08 M(-42.9%)
$1.08 M(-20.2%)
Sep 2016
-
$1.36 M(-12.7%)
Jun 2016
-
$1.56 M(-17.2%)
Mar 2016
-
$1.88 M(-0.6%)
Dec 2015
$1.89 M(-16.4%)
$1.89 M(-30.8%)
Sep 2015
-
$2.73 M(-7.6%)
Jun 2015
-
$2.96 M(+7.7%)
Mar 2015
-
$2.75 M(+21.4%)
Dec 2014
$2.26 M(-8.7%)
$2.26 M(-12.8%)
Sep 2014
-
$2.59 M(-11.7%)
Jun 2014
-
$2.94 M(+12.1%)
Mar 2014
-
$2.62 M(+5.8%)
Dec 2013
$2.48 M(+88.9%)
$2.48 M(+135.5%)
Sep 2013
-
$1.05 M(-14.2%)
Jun 2013
-
$1.23 M(-3.5%)
Mar 2013
-
$1.27 M(-3.1%)
Dec 2012
$1.31 M(-37.5%)
$1.31 M(+5.9%)
Sep 2012
-
$1.24 M(+4.1%)
Jun 2012
-
$1.19 M(-4.3%)
Mar 2012
-
$1.24 M(-40.8%)
Dec 2011
$2.10 M(+35.9%)
$2.10 M(+32.4%)
Sep 2011
-
$1.59 M(-4.3%)
Jun 2011
-
$1.66 M(-2.9%)
Mar 2011
-
$1.71 M(+10.5%)
Dec 2010
$1.54 M
$1.54 M(-19.1%)
DateAnnualQuarterly
Sep 2010
-
$1.91 M(+3.2%)
Jun 2010
-
$1.85 M(-5.1%)
Mar 2010
-
$1.95 M(+0.8%)
Dec 2009
$1.92 M(+33.7%)
$1.93 M(+28.4%)
Sep 2009
-
$1.51 M(+5.4%)
Jun 2009
-
$1.43 M(+5.8%)
Mar 2009
-
$1.35 M(-7.2%)
Dec 2008
$1.44 M(-34.3%)
$1.45 M(-15.8%)
Sep 2008
-
$1.73 M(-16.2%)
Jun 2008
-
$2.06 M(-1.3%)
Mar 2008
-
$2.09 M(-5.2%)
Dec 2007
$2.19 M(+128.6%)
$2.20 M(+38.3%)
Sep 2007
-
$1.59 M(+6.7%)
Jun 2007
-
$1.49 M(+58.0%)
Mar 2007
-
$944.80 K(-1.2%)
Dec 2006
$956.10 K(-9.0%)
$956.60 K(-10.2%)
Sep 2006
-
$1.07 M(-0.8%)
Jun 2006
-
$1.07 M(+2.8%)
Mar 2006
-
$1.04 M(-0.6%)
Dec 2005
$1.05 M(+134.8%)
$1.05 M(+132.6%)
Sep 2005
-
$452.10 K(+1.2%)
Jun 2005
-
$446.80 K(-0.4%)
Mar 2005
-
$448.40 K(+0.2%)
Dec 2004
$447.70 K(+353.1%)
$447.50 K(+109.7%)
Sep 2004
-
$213.40 K(+45.4%)
Jun 2004
-
$146.80 K(-13.7%)
Mar 2004
-
$170.20 K(+71.9%)
Dec 2003
$98.80 K(-76.9%)
$99.00 K(-55.1%)
Sep 2003
-
$220.60 K(-43.5%)
Jun 2003
-
$390.30 K(-8.3%)
Mar 2003
-
$425.50 K(-0.9%)
Dec 2002
$428.30 K(-22.8%)
$429.40 K(+10.7%)
Sep 2002
-
$388.00 K(-16.5%)
Jun 2002
-
$464.70 K(+6.5%)
Mar 2002
-
$436.50 K(-21.6%)
Dec 2001
$555.10 K(+75.9%)
$556.90 K(-5.4%)
Sep 2001
-
$588.90 K(-8.5%)
Jun 2001
-
$643.60 K(+20.7%)
Mar 2001
-
$533.30 K(+68.9%)
Dec 2000
$315.50 K(+402.4%)
$315.70 K(+679.5%)
Sep 2000
-
$40.50 K(-40.0%)
Jun 2000
-
$67.50 K(-83.7%)
Mar 2000
-
$413.10 K(+554.7%)
Dec 1999
$62.80 K(-2.8%)
$63.10 K(-7.3%)
Sep 1999
-
$68.10 K(+0.4%)
Jun 1999
-
$67.80 K(+2.3%)
Mar 1999
-
$66.30 K(+2.0%)
Dec 1998
$64.60 K(-69.1%)
$65.00 K(-0.8%)
Sep 1998
-
$65.50 K(-90.4%)
Jun 1998
-
$680.70 K(-3.4%)
Mar 1998
-
$704.50 K(+236.1%)
Dec 1997
$209.30 K(-94.4%)
$209.60 K(-94.2%)
Sep 1997
-
$3.62 M(-5.7%)
Jun 1997
-
$3.84 M(-1.9%)
Mar 1997
-
$3.91 M
Dec 1996
$3.72 M
-

FAQ

  • What is COSCIENS Biopharma annual total long term liabilities?
  • What is the all time high annual total long term liabilities for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual total long term liabilities year-on-year change?
  • What is COSCIENS Biopharma quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly long term liabilities year-on-year change?

What is COSCIENS Biopharma annual total long term liabilities?

The current annual total long term liabilities of CSCI is $1.40 M

What is the all time high annual total long term liabilities for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual total long term liabilities is $3.72 M

What is COSCIENS Biopharma annual total long term liabilities year-on-year change?

Over the past year, CSCI annual total long term liabilities has changed by -$1.07 M (-43.34%)

What is COSCIENS Biopharma quarterly total long term liabilities?

The current quarterly long term liabilities of CSCI is $15.59 M

What is the all time high quarterly long term liabilities for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly total long term liabilities is $15.59 M

What is COSCIENS Biopharma quarterly long term liabilities year-on-year change?

Over the past year, CSCI quarterly total long term liabilities has changed by +$14.19 M (+1016.38%)